

6 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Eventide Healthcare Innovation Fund IIFiled to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| Eventide Healthcare Innovation Fund I | November 2022 | Indefinite | $65M | 47 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
8 partners are named across this firm’s filings, 6 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Dolores Bamford | Quiet | None listed | 0 | 0 |
Categories of Eventide Healthcare Innovation’s own portfolio companies, based on 3 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Eventide Healthcare Innovation’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| NEA | 1 | Curzion Pharmaceuticals |
| Omega Funds | 1 | Beta Bionics |
A shared board seat: a company where filings name a Eventide Healthcare Innovation partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
| Finny Kuruvilla | Quiet | Medical devices | 1 | 0 |
| I-hung ShihNot on the current fund | Quiet | None listed | 0 | 0 |
| Jennifer Reiche | Quiet | None listed | 0 | 0 |
| Kyle Rasbach | Quiet | Biotech & pharma | 2 | 0 |
| Peter LuisoNot on the current fund | Quiet | None listed | 0 | 0 |
| Robin John | Quiet | None listed | 0 | 0 |
| Sean Mathew | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.